Novel therapeutic possibilities for chemorefractory ovarian cancer patients identified by functional ex vivo drug sensitivity testing of primary cells




Murumagi A, Hirasawa A, Khan S, Arjama M, Pellinen T, Koivisto-Korander R, Leminen A, Magi A, Aittokallio T, Butzow R, Kallioniemi O

PublisherLIPPINCOTT WILLIAMS & WILKINS

2016

International Journal of Gynecological Cancer

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

INT J GYNECOL CANCER

26

653

653

1

1048-891X




Last updated on 2024-26-11 at 12:15